2026-10-06 · 2026-10 / week-1
PTC’s fixed $205 offer leaves too little upside for a long
PTC’s fixed $205 offer leaves too little upside for a long
Summary: Schneider Electric’s signed all-cash offer caps PTC common-stock consideration at $205, while the latest timestamped Oct. 5 trade reference reviewed was $193.01. That is only 6.2% gross upside, with no interest, to an expected Q3 2027 close; a deal failure could return the shares toward the Oct. 2 $144.03 close, a 25.4% downside stress. The deal is definitive and has no financing condition, but shareholder, HSR and CFIUS approvals remain. Reject / U.S. long-only no-trade screen. Publication basis: Oct. 6, 2026, 00:59 SGT.
Opportunity Ranking
| Rank | Candidate | Direction | Mispricing | Evidence Freshness | Catalyst Window | Positioning | 10/5 Status | Tradeability | Main Rejection Risk |
|---|---|---|---|---|---|---|---|---|---|
| 1 | PTC Inc. (PTC) | Long | Fixed $205 cash consideration versus an Oct. 5 $193.01 last-trade reference; the spread implies roughly 80% completion probability if failure returns to the unaffected close | Oct. 5 merger agreement and SEC 8-K; Oct. 5 12:44 p.m. EDT market mark | PTC shareholder vote and HSR/CFIUS; close anticipated by Q3 2027 | Merger-arbitrage ownership, borrow and options positioning not checked | Reject: maximum deal-close return +6.2%; failure stress -25.4%; gross base/adverse 0.25:1 | Nasdaq common stock; current spread, depth, venue and exit capacity not audited | Regulatory or shareholder failure; no-interest wait; standalone price may fall below unaffected close |
| 2 | RXO Inc. (RXO) | Long | Cash-and-stock consideration floats with CHRW; at its Oct. 5 reference, stated mixed consideration is about $29.11 versus RXO at $28.53 | Oct. 5 merger terms and current finance-feed reference | Expected close first half 2027, subject to shareholder and regulatory approvals | 17.04% holder support agreement is disclosed; broader arbitrage positioning not checked | Reject: only about 2.0% gross at current component prices before proration, carry or costs | NYSE common stock; current executable spread and election capacity not audited | 57% aggregate cash/43% stock proration; CHRW price moves change the value |
| 3 | C.H. Robinson (CHRW) | Long | Acquirer shares fell about 12.1% in the same session; the deal adds scale and claimed synergies but also new debt, equity consideration and a buyback pause | Oct. 5 merger release; current finance-feed reference | Integration and claimed $300M net run-rate synergies within two years after close | Deal-related flows not isolated | Reject: price drop alone does not establish a +10% base or post-deal per-share value | Nasdaq common stock; no standalone post-announcement valuation/execution audit | Synergies may be delayed or offset by freight-cycle weakness, leverage and issuance |
| Control | SPDR S&P 500 ETF (SPY) | Long | Broad-market control; no deal-specific payoff | Oct. 5 intraday reference | None | Not assessed | No selected setup | Reference only | Index return does not remove single-deal closing risk |
Selected opportunity: PTC as the cleanest measurable rejection, not the best executable opportunity.
Why this one now: PTC’s consideration is fixed in cash, so unlike RXO the nominal payout does not move with the buyer’s share price. The remaining spread can be translated into an approximate binary closing probability, then challenged against the agreement’s actual approval conditions and downside if the deal terminates.
What should surprise the reader: The often-quoted 42.3% premium is measured from PTC’s unaffected Oct. 2 close. After the shares repriced on Oct. 5, even certain receipt of $205 is only about 6.2% above the latest timestamped market mark.
Why This Is the Best Opportunity Right Now
On Oct. 4 PTC, Schneider Electric and a wholly owned merger subsidiary signed a definitive merger agreement. PTC’s board unanimously approved it and recommends shareholder approval. Schneider will pay $205 cash per PTC common share at closing, without interest. The companies anticipate closing by Q3 2027.
This is a more measurable event path than RXO’s current mixed cash/share value, which changes with CHRW and is subject to proration, or CHRW’s acquirer-side rerating, which requires a pro forma debt, share-count and synergy bridge. PENG remains a useful operating-growth comparison, but its Oct. 6 FY2026 result is not a new deal spread and its earlier long screen already found no 10/5 edge. This is not a quote refresh of the recent Qorvo or Synaptics merger screens: PTC adds a newly signed, fixed-cash agreement, no financing condition, cross-border CFIUS review and a Q3 2027 close expectation. The new evidence boundary is the actual signed $205 obligation and conditions, while the market has already repriced the target. The question is whether a roughly one-year wait for $205 compensates for the limited residual upside and much larger break-risk drawdown.
The strongest bull case is real: the merger is signed, both boards unanimously approved it, the purchaser has a committed bridge facility, and closing is not conditioned on financing. Those facts reduce some completion risks. They do not remove the required PTC shareholder vote, U.S. antitrust review, CFIUS review, other specified regulatory clearances, or the agreement’s other conditions.
Why This Can Move More Than 5% Soon
PTC shares had an unaffected Oct. 2 regular close of $144.03. The offer’s $205 consideration is a 42.3% premium to that close, as stated by the companies. The latest timestamped market-data reference retrieved for this screen is $193.01 at 12:44:53 p.m. EDT on Oct. 5, up $48.98 or 34.01% from the previous close. It leaves $11.99, or 6.2%, to the fixed cash offer.
The price may still rise if the market marks the probability or timing of completion differently; it may gap lower if approvals fail, a condition is breached, or the agreement terminates. No live bid/ask spread, order-book depth, venue, volume-quality or realistic exit-capacity evidence was verified. The intraday trade reference is context only, not an executable entry.
10/5 Asymmetry Gate
| Test | Result |
|---|---|
| Reference basis | PTC $193.01 at 12:44:53 p.m. EDT Oct. 5 last-trade reference; not an entry |
| Contractual top / highest-probability base | $205.00 cash if the merger closes; +6.2% gross before costs |
| Credible failure stress | $144.03, the Oct. 2 unaffected close; -25.4%. Not a floor or maximum-loss estimate |
| Approximate binary close probability implied by mark | 80.3%, assuming failure value of $144.03 and ignoring time value, fees, dividends, taxes and other recovery paths |
| Illustrative weighted map | $192.81 at 10% early close / 70% close by Q3 2027 / 20% failure; -0.1% before costs |
| Gross base/adverse ratio | 0.25:1 |
| Costs / execution | Carry, spread, slippage and exit costs not estimated; live spread/depth/venue/exit audit missing |
| Status | Reject / no trade |
Even with a 100% probability of closing, the $205 payment yields only 6.2% from the current reference, below the Desk’s +10% highest-probability base hurdle. At the illustrative 80% close / 20% failure split, probability-weighted price is $192.81, slightly below the reference before time value and costs. The current price therefore supplies no independent evidence of an attractive long; the 80.3% figure is a simple price-implied probability under a two-outcome assumption, not a forecast.
What Should Surprise the Reader
The transaction is not conditioned on Schneider obtaining financing. Schneider has a $25 billion bridge financing commitment, and the buyer’s release says it expects a funding mix of roughly €5–6 billion equity and €16–17 billion new debt. Those facts lower financing-condition risk for PTC shareholders, but do not make the spread risk-free or bind the regulators.
PTC must obtain approval from holders of a majority of its outstanding shares and specified antitrust and foreign-investment clearances, including HSR and CFIUS. The agreement also requires absence of specified prohibitory orders, compliance with covenants, accuracy of representations subject to negotiated standards, and no continuing material adverse effect. A $700 million termination fee is payable by PTC only in specified target-side circumstances such as certain superior-offer or recommendation-change paths; it is not a universal payment to shareholders if the deal fails.
The Setup
Fact: The Oct. 4 merger agreement converts each eligible PTC common share into the right to receive $205 cash at the effective time, without interest and subject to withholding. The boards of PTC, Schneider Electric and the merger subsidiary approved the transaction. PTC’s board recommends that shareholders approve it.
Fact: Closing requires PTC shareholder approval and specified regulatory approvals, including HSR and CFIUS clearances. Schneider’s bridge commitment is documented, and the merger is expressly not conditioned on obtaining financing. Company guidance anticipates closing by Q3 2027.
Inference: Comparing the Oct. 5 market mark with the fixed consideration and unaffected close gives a rough two-state implied completion probability of 80.3%. This is only arithmetic under a binary model; a long hold, alternative break value, daily price risk, transaction amendments and risk-free carry all affect the true required probability. The calculation cannot prove the offer is mispriced.
Unknown: PTC’s standalone fair value after a failed transaction; timing and resolution of HSR/CFIUS review; litigation or remedy risk; current merger-arbitrage ownership and hedging; live spread, depth, venue and exit capacity; and the actual probability and timing of shareholder approval and completion.
The Market Price
| Observation | Price / value | Use |
|---|---|---|
| PTC Oct. 5 intraday last-trade reference, 12:44:53 p.m. EDT | $193.01 | Post-announcement reference; not executable |
| PTC Oct. 5 reported open / high / low | $195.75 / $198.30 / $186.00 | Finance-feed session context |
| PTC Oct. 5 reported volume at 12:44:53 p.m. EDT | 19.62M shares | Provider snapshot; not a volume-quality audit |
| PTC Oct. 2 regular close, 4:00 p.m. EDT | $144.03 | Last completed close before the announcement; unaffected reference |
| Merger consideration | $205 cash per eligible common share, without interest | Contractual consideration only if closing conditions are met |
| Deal announcement premium to Oct. 2 close | 42.3% | Issuer-stated premium, not upside from the Oct. 5 reference |
| PTC implied equity value / enterprise value | ~$22.6B / ~$23.7B | Issuer-stated transaction values |
| RXO live reference / CHRW live reference | $28.53 / $138.58 | Intraday finance-feed references; transaction math below is indicative |
| RXO mixed consideration at current CHRW mark | ~$29.11 = $17.25 + 0.0856 × $138.58 | Not guaranteed payout; election proration applies |
| CHRW / SPY intraday references | $138.58 / $774.47 | Broad event-day and market controls |
The Mispricing
The candidate disagreement is between the market price and the contractual cash payment. At $193.01, the simple two-outcome price arithmetic treats completion as roughly 80.3% likely if a failed transaction returns PTC only to $144.03. That is an inference, not observed odds. It ignores time value and carrying costs, so the actual completion probability required for a positive net return would be higher unless the expected failure value is higher than the unaffected close.
The market may be right to discount closing risk: the offer crosses jurisdictions and requires HSR and CFIUS review plus PTC shareholder approval, while the payment does not accrue interest. The market may also be too pessimistic if the regulatory path clears without significant remedy and approval proceeds on schedule. We do not have evidence to select an independently estimated probability above the price-implied hurdle, and even certain closing does not clear +10% from today’s mark.
The Positioning
No current PTC short-interest settlement, merger-arbitrage ownership, borrow utilization, option open interest, implied volatility, dealer exposure or fund-flow data were verified. The 34.01% move and 19.62 million reported shares by 12:44 p.m. do not identify which investors own the deal spread or whether they are hedged with Schneider or other securities. Positioning remains unknown.
The Catalyst
| Step | State and timing | Observable test | Failure or delay path |
|---|---|---|---|
| Signed merger agreement | Completed Oct. 4; announced Oct. 5 | Review the definitive proxy, offer terms, amendments and board recommendation | Superior proposal, litigation or changed terms may alter the expected payout |
| PTC shareholder approval | Pending; majority of outstanding shares required | Review proxy filing, meeting date, vote tally and any changes in board recommendation | Insufficient votes, delay or recommendation change |
| HSR / CFIUS / other regulatory clearances | Pending; required closing conditions | Track official filings, clearance notices, waiting-period expiry and any remedy or order | Extended review, conditions, prohibition or failure to clear |
| Financing | Bridge commitment reported; deal is not conditioned on financing | Check any material amendment to commitment or merger agreement | Commitment is strong evidence but does not remove other conditions |
| Closing/payment | Anticipated by Q3 2027 | Confirm effective time, delisting and payment-agent settlement of $205 per eligible share | Termination leaves PTC as a standalone company, potentially below the unaffected reference |
Cheapest falsification sequence: Read the filed proxy and merger agreement; monitor the HSR and CFIUS status; check any amendment, remedy, litigation or recommendation change; then compare the live post-announcement spread with a revised standalone downside model. The Oct. 2 close is not a protected floor.
The Payoff
Only unlevered PTC common stock is screened. It would receive $205 cash at closing if eligible and if the merger closes, without interest. The simple best-case price gain from the latest reference is 6.2% over an expected period ending by Q3 2027. There is no contractual upside above $205 for common shares under the current agreement; a topping bid would be a separate, unverified event.
RXO provides a different but less fixed comparator: the official mixed consideration is $17.25 plus 0.0856 CHRW shares, and cash-only elections are subject to aggregate proration. With CHRW at $138.58, the standard mixed value is about $29.11 versus RXO at $28.53, approximately 2.0% gross before deal risk and costs. CHRW’s 12.1% decline highlights acquirer financing and dilution concerns, but does not itself establish a long on the buyer.
Price Target and Probability Map
A fundamental standalone PTC value cannot be responsibly quantified in this screen. The following reference scenario map runs through Sep. 30, 2027, the end of the announced Q3 2027 expected close window. Top and base share the same $205 contractual amount because the agreement is fixed cash; they differ only in the assumed completion timing. The 20% failure stress uses the last unaffected close and is not a floor. The 10% / 70% / 20% weights are a low-confidence illustration whose aggregate 80% completion weight is rounded from the approximately 80.3% two-state probability implied by the current reference under the stated assumptions; it is not an independent probability forecast.
| Scenario | Probability | Target / Level | Return / Payoff | Horizon | Conditions | Evidence Quality |
|---|---|---|---|---|---|---|
| Top Case | 10% | $205.00 | +6.2% | Through Sep. 30, 2027 | Merger closes ahead of the announced Q3 2027 window | Low; same contracted consideration, earlier timing judgment |
| Base Case | 70% | $205.00 | +6.2% | Through Sep. 30, 2027 | Merger closes on the company’s anticipated schedule | Low; completion probability not independently estimated |
| Bottom Case | 20% | $144.03 | -25.4% | Through Sep. 30, 2027 | Merger terminates and PTC returns to the Oct. 2 unaffected close as a reference stress | Low; historical price, not fundamental value or bounded loss |
| Invalidation | n/a | Amended consideration, superior proposal, termination, or regulatory/shareholder result changes the contractual path | Replace the deal map with a fresh standalone or amended-deal model | On new primary evidence | Recompute from the amended terms and a fresh market observation | High when contractually disclosed |
Probability-weighted expected value: $192.81, about -0.1% gross versus $193.01. Carry, transaction and execution costs are not deducted because they are unverified; the gross calculation offers no margin.
Current market level and timestamp: PTC $193.01 at 2026-10-05 12:44:53 p.m. EDT / 16:44:53 UTC, intraday regular-session last-trade reference.
Primary instrument: PTC common stock, considered but not recommended.
10/5 favorable base move: +6.2% if the $205 cash consideration is paid, below the +10% hurdle.
10/5 credible adverse move: -25.4% to the unaffected-close stress; losses could be larger.
10/5 measurement basis: Reference-only; entry is null.
10/5 status: Reject / no trade.
Confidence: High that the maximum contractual close payoff from this reference fails +10%; low on deal-close odds and the standalone downside.
Sensitivity and break-even
At the selected failure stress, a deal-completion probability of about 80.3% is required for zero gross expected return before carry: (193.01 − 144.03) ÷ (205 − 144.03). This is nearly the current deal-marked price by construction, not an independent edge. If completion probability is 75%, the same two-outcome map yields about -1.7% gross expected return; at 90%, about +3.0%. Even 100% completion yields only +6.2%, so this merger alone cannot satisfy the +10% base hurdle from the Oct. 5 mark.
The Kill Shot
Strongest counterargument: Both boards unanimously approved the agreement; PTC’s board recommends it; the $205 cash offer is definitive; Schneider has a committed $25 billion bridge; and the agreement has no financing condition. The target-side $700 million fee in specified superior-proposal/recommendation-change scenarios may discourage a competing bid. Those facts support a meaningful probability of completion.
Why it still fails: The contractual payment is capped at $205 and the current reference is already $193.01. Even a perfect close is +6.2% gross, and the expected wait is roughly a year. An 80.3% simple market-implied close probability leaves no gross expected value under the historical failure stress; required carry and execution costs push the hurdle higher. HSR, CFIUS and shareholder approval remain unsatisfied.
Load-bearing assumption: $144.03 is a relevant downside stress after termination. That is only the last close before deal news, not intrinsic value or a loss bound; standalone price could be lower. This makes the downside risk larger, not smaller, than the map may suggest.
What Could Go Wrong
- HSR or CFIUS review, a court order, litigation, shareholder vote or a material adverse event delays, conditions or prevents closing.
- PTC’s stand-alone price may fall below $144.03 if the transaction terminates; the old close is not a floor.
- The offer pays no interest, and expected Q3 2027 timing creates time-value and opportunity-cost exposure.
- A better bid is not established. The $700 million fee applies only in specified PTC-side termination paths and does not protect holders from all regulatory or closing failures.
- The bridge is committed and financing is not a merger condition, but funding documentation, capital-markets plans and buyer leverage still matter to Schneider’s broader shareholder economics.
- A live finance-feed last trade is not an executable bid. Spread, depth, venue, price impact and realistic exit capacity are unaudited.
- A deal break can gap PTC below the prior close; a stop cannot cap that loss.
What Would Prove This Wrong
The Reject should be reopened only if a materially higher offer or amended consideration is announced, or if a revised analysis finds an independently defensible completion probability and after-cost return that meets the Desk’s hurdle from a fresh reference. A definitive proxy, completed shareholder vote and actual HSR/CFIUS clearance can lower uncertainty, but they do not increase the fixed $205 payoff. The thesis is invalidated if the agreement terminates, terms change, or actual consideration differs.
Risk Audit
| Question | Assessment |
|---|---|
| Strongest counterparty case | Signed, board-approved $205 cash offer; no financing condition; committed bridge |
| Most fragile assumption | Deal failure returns to the unaffected $144.03 close; price could be lower |
| What the market may already know | Current deal-marked reference implies roughly 80.3% binary completion odds before carry under the two-price model |
| Directionally right but losing | Deal closes, but the capped gross gain is too small for the wait, costs and risk budget |
| Gap risk | High at regulatory, shareholder, litigation or agreement updates |
| Positioning | Current merger-arbitrage holdings, short interest and hedges not verified |
| Execution state | Entry null; execution false; current last-trade reference only |
| Protection | No verified hedge or defined-loss expression; merger spread is not principal protection |
Best Trade Strategy
No trade. Do not buy PTC simply because $205 exceeds the current price. The maximum contractual payout is only 6.2% above the intraday reference, the failure stress is substantially larger, and the probability-weighted gross map is slightly negative before carry. No options, leverage, margin, market orders or price-floor language are used.
Revisit only after the proxy and vote timing are public, the HSR/CFIUS path is observable, or the transaction terms change. If no live spread, depth and exit evidence is available when any future entry is considered, retain null entry and execution false.
Sources
- PTC Oct. 5 Form 8-K, primary filing for the Oct. 4 merger agreement, $205 cash consideration, closing conditions, no-financing condition, $700 million termination fee in specified paths and $25 billion bridge commitment.
- PTC merger agreement, Exhibit 2.1, contract text for consideration, closing process, conditions and termination terms.
- PTC and Schneider Electric joint Oct. 5 announcement, issuer statements on the expected Q3 2027 close, funding mix and transaction economics.
- PTC Oct. 2 price history, secondary dated close of $144.03 before the deal announcement.
- PTC market quote page, secondary market reference; the selected $193.01 observation is a finance-feed last trade at 16:44:53 UTC on Oct. 5, not a verified bid or executable price.
- C.H. Robinson Oct. 5 SEC Form 8-K, primary RXO transaction terms, consideration elections, proration, approval conditions and financing.
- RXO market quote page, secondary current reference.
- CHRW market quote page, secondary current reference.
- Penguin Solutions Q3 FY2026 results and Q4/FY2026 report-date notice, comparison against a fresh operating-growth candidate screened earlier in the week.
- SPY market quote page, broad-market control only.
Research Quality Scorecard
| Criterion | Score | Evidence-based reason |
|---|---|---|
| Market disagreement | 4/5 | Contractual $205 ceiling versus $193.01 event-marked price is explicit; implied close odds are calculable but not independent |
| Evidence base | 5/5 | Fresh SEC agreement/8-K and clearly timestamped price reference; regulatory path remains pending |
| Positioning and flows | 2/5 | Deal-arbitrage holdings, hedges, short interest and live order-book conditions not checked |
| Catalyst path | 4/5 | Shareholder, HSR, CFIUS and expected close milestones are observable |
| Payoff architecture | 2/5 | Fixed payout is clear but max upside fails +10%, failure stress exceeds -5%, and gross ratio is weak |
| Invalidation discipline | 5/5 | Amended terms, votes, clearances or termination are observable |
| Differentiated insight | 4/5 | Separates the 42.3% premium to unaffected close from only 6.2% remaining upside after the event repricing |
| Client value | 5/5 | Quantifies the spread, market-implied completion threshold and downside asymmetry without presenting it as a trade |
Total: 31/40. Publishable as a substantive no-trade screen. The score does not override the failed 10/5 economics.
Bottom Line
PTC’s merger agreement creates a clean contractual $205 cash payoff, but the market had already repriced the shares to $193.01 by the latest timestamped trade reference. The remaining upside is at most 6.2% before costs and requires waiting for a Q3 2027 expected close, while the failure path can erase substantially more. The agreement is strong evidence of a deal, not proof of an attractive post-announcement long. No trade.
AI Illustration Prompt
Create a restrained institutional illustration for The Mispricing Desk: a price bridge with “OCT 2 UNAFFECTED CLOSE $144.03,” “OCT 5 LAST-TRADE REFERENCE $193.01,” and “CONTRACT CASH $205.00” as three clearly separated markers. Above the last marker show “MAX REMAINING UPSIDE 6.2% GROSS”; below show an amber downside bracket “DEAL FAILS: $144.03 HISTORICAL STRESS, NOT A FLOOR.” Place a transaction checklist to the side: “PTC VOTE PENDING,” “HSR PENDING,” “CFIUS PENDING,” “NO FINANCING CONDITION,” and “EXPECTED CLOSE Q3 2027.” Use graphite, paper white and restrained amber; no arrows implying certainty or guaranteed return; add a subtle readable “The Mispricing Desk” watermark in the lower-right corner.